To provide a composition and a method for treating neoplasms in mammals, particularly humans.
There are provided a method for preventing, treating or delaying neoplasm in a mammal using an ErbB-3 protein, a nucleic acid encoding the ErbB-3 protein or a functional fragment of the protein; isolated nucleic acids encoding an extracellular domain of the ErbB-3 protein or its functional fragment, substantially purified extracellular domain of the ErbB-3 protein or its functional fragment and antibodies that bind to an epitope in the extracellular domain of the ErbB-3 protein or its functional fragment; and pharmaceutical compositions and/or vaccines comprising the extracellular domain of the ErbB-3 protein or its functional fragment, or encoding nucleic acids and antibodies binding to such extracellular domain or its functional fragments.
JP2000515372A | 2000-11-21 |
JPN6009026092; Proc. Natl. Acad. Sci. USA. Vol.87, 1990, p.4905-4909
Arihara Koichi
Matsushima Tetsuo
Next Patent: RIDING TYPE WORKING MACHINE